Pimitespib + Imatinib
NCT05245968
Taiho Pharmaceutical · Phase 1 · Active, not recruiting · Enrollment 78
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Pimitespib + Imatinib
Taiho Pharmaceutical · Phase 1 · Active, not recruiting · Enrollment 78
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.